Copyright
©The Author(s) 2020.
World J Gastrointest Oncol. Dec 15, 2020; 12(12): 1428-1442
Published online Dec 15, 2020. doi: 10.4251/wjgo.v12.i12.1428
Published online Dec 15, 2020. doi: 10.4251/wjgo.v12.i12.1428
Table 1 Patient and treatment characteristics (n = 88), n (%)
| Characteristic | n = 88 |
| Age, median (yr, range) | 63 (34-93) |
| Sex | |
| Male | 42 (47.7) |
| Female | 46 (52.3) |
| Location | |
| Colon | 25 (28.4) |
| Rectum | 63 (71.6) |
| cT stage | |
| T4a | 44 (50) |
| T4b | 44 (50) |
| cN stage | |
| N0 | 7 (8) |
| N1 | 37 (42) |
| N2 | 44 (50) |
| cTNM stage | |
| II | 6 (6.8) |
| III | 82 (93.2) |
| Tumor grade | |
| Well differentiated | 4 (4.6) |
| Moderately differentiated | 72 (81.8) |
| Poorly differentiated | 12 (13.6) |
| Pretreatment CEA (ng/mL) | |
| ≤ 5 | 46 (52.3) |
| > 5 | 42 (47.7) |
| Preoperative chemotherapy | |
| FOLFOX | 75 (85.2) |
| Capecitabine | 13 (14.8) |
| Radiation technique | |
| Tomotherapy | 24 (27.9) |
| Volumetric arc therapy | 49 (57) |
| Conformal radiotherapy | 15 (15.1) |
| Radiation dose (Gy) | |
| < 50 | 26 (29.5) |
| ≥ 50 | 62 (70.5) |
| Radiation-surgery interval (wk, range) | 9 (5-40) |
- Citation: Huang CM, Huang CW, Ma CJ, Tsai HL, Su WC, Chang TK, Huang MY, Wang JY. Outcomes of neoadjuvant chemoradiotherapy followed by radical resection for T4 colorectal cancer. World J Gastrointest Oncol 2020; 12(12): 1428-1442
- URL: https://www.wjgnet.com/1948-5204/full/v12/i12/1428.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v12.i12.1428